Guillaume Monneret to Critical Illness
This is a "connection" page, showing publications Guillaume Monneret has written about Critical Illness.
Connection Strength
0.173
-
Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome. Crit Care. 2021 04 12; 25(1):140.
Score: 0.041
-
Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient. Cell Mol Immunol. 2020 09; 17(9):1001-1003.
Score: 0.039
-
Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients. Intensive Care Med. 2020 Sep; 46(9):1764-1765.
Score: 0.039
-
Low Interleukin-7 Receptor Messenger RNA Expression Is Independently Associated With Day 28 Mortality in Septic Shock Patients. Crit Care Med. 2018 11; 46(11):1739-1746.
Score: 0.035
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
Score: 0.011
-
The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open. 2017 06 21; 7(6):e015734.
Score: 0.008